Stock·NYSE·Consumer Defensive
Constellation Brands Inc. Class A (STZ)
- Market cap
- $22.11B
- P/E
- 11.69
- Dividend yield
- 3.14%
- Street target
- $150.00median of 24 analysts
- 52-week range
- $110.60 $168.60
STZ stock forecast today
Where STZ stands today, and what CleaRank Financial AI makes of it.
STZ at a glance
Constellation Brands Inc. Class A (STZ): Buy, 63/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($125.47 and $142.15).
- Earnings STZ beat estimates in 5 of the 6 reports in our data, and the stock rose the next day every time.
- Insiders Insiders sold $1.8M and bought $341K over the last 18 months.
- Valuation P/E of 11.7 against 24.2 for the Consumer Defensive sector: a discount to peers (-52%).
Figures as of October 27, 2026.
CleaRank Financial AI
CleaRank rates Constellation Brands Inc. Class A (STZ) a Buy with a model score of 63/100.
The biggest lift to that score comes from valuation: the P/E of 11.69 is 51.7% below the sector median, a discount to peers. The trend holds the score back the most, with the price 8.11% below its 200-day average and the 50-day average 11.74% below the 200-day. The 50-day average is $125.47 and the 200-day is $142.15. Over the past year the price fell 5.31%.
Only on CleaRank
Figures we compute ourselves from STZ's own price, earnings and insider-filing history. Tap one to see it in context.
STZ stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $130.63 is 4.1% above the 50-day simple moving average of $125.47.Price above its 200-day average ›
The price is 8.1% below the 200-day simple moving average of $142.15.50-day average above the 200-day ›
The 50-day average ($125.47) is 11.7% below the 200-day average ($142.15), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 35% of its 52-week range, between $110.60 and $168.60.
STZ share price
Pick a period: each tab shows how far STZ has moved over it, to the last close.
Today's trading
Where STZ sits inside today's range and its 52-week range.
STZ fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 11.69 is 51.7% below the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 2.40 is 9.1% above the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $1.9B on revenue of $9.2B, a net margin of 20.9%.Beat estimates in most recent reports ›
STZ beat the EPS estimate in 5 of the 6 reports in our data.Pays a dividend ›
The trailing dividend yield is 3.14%, or $4.10 a share a year.
Key statistics
The headline figures for STZ.
As of October 27, 2026, STZ trades at $130.63, with a market value of $22.11B, a P/E ratio of 11.69 and a dividend yield of 3.14%.
What the numbers say
CleaRank Financial AI's reading of STZ's valuation, growth and risks.
Consumer Defensive stocks have a median P/E of 24.2. Constellation Brands Inc. Class A (STZ) trades at a P/E of 11.69, which is 51.7% below that median and marks it as a discount to peers. Measured against sales, the P/S of 2.40 is 9.1% above the sector median of 2.2.
STZ turns sales into profit at a net margin of 20.90% and an operating margin of 33.58%, alongside a return on equity of 24.01%, above the sector median of 19.7%. Debt-to-equity of 1.16 and a trailing dividend yield of 3.14% ($4.10 a share a year) round out the fundamentals.
Constellation Brands Inc. Class A (STZ) topped expectations in its October 6, 2026 report, with EPS of $3.74 against the $3.55 analysts had forecast, a beat of 5.35%. In the first session after the report, the share price went up 2.35%.
STZ beat the EPS estimate in 5 of the 6 reports in our data, and the stock rose in the first session after each of those beats. Of the 3 reports before the latest, the largest reaction came after the April 8, 2026 report, which beat the estimate by 11.11% while the stock rose 8.53%. Analysts' average EPS estimate for this fiscal year is $11.82, which would be a decline of 0.0%, and $12.10 for next year (growth of 2.4%).
STZ's daily returns have a 30-day standard deviation of 1.91%, and the beta against the S&P 500 is 0.43. Meanwhile, the price sits 22.52% below the 52-week high of $168.60.
STZ against the Consumer Defensive sector
How STZ compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: STZ trades at a notable discount to sector peers (-52%), which may indicate undervaluation or specific company headwinds.
Return vs SPY: Since May 15, 2025, STZ has lost 31.5% against a gain of 30.4% for SPY.
Performance against SPY
STZ and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much STZ sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to May 31, 2026); STZ reported again on October 6, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue fell 10.5% in FY2026 to $9.1B, from $10.2B a year earlier.
Profit margin: The net margin was 19.2% in FY2026, up from -0.3% the year before.
Profitable: STZ earned $1.8B in FY2026.
Earnings reality check
Did STZ beat what analysts expected, and how did the stock react?
Earnings record: STZ beat the analyst estimate in 5 of the 6 reports in our data.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 6, 2026after close | $3.55 | $3.74 | +5.35% | +2.35% | +9.85% |
| Apr 8, 2026after close | $1.71 | $1.90 | +11.11% | +8.53% | +9.11% |
| Jan 7, 2026after close | $2.63 | $3.06 | +16.35% | +5.32% | +11.30% |
| Oct 6, 2025after close | $3.41 | $3.63 | +6.45% | +1.03% | +1.97% |
| Jul 1, 2025after close | $3.29 | $3.22 | -2.13% | +4.48% | +1.57% |
| Apr 9, 2025after close | $2.27 | $2.63 | +15.86% | +0.74% | -0.20% |
As of October 27, 2026, STZ has beaten the analyst EPS estimate in 5 of the 6 reports in our data and rose in the first trading session after every one of those beats; its latest report, on October 6, 2026, came in 5.35% above the estimate and the stock moved +2.35% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
STZ AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 56.0, in neutral territory.RSI above 50 ›
An RSI of 56.0 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of STZ
The score, the reasoning behind it, and what could move the price next.
Constellation Brands Inc. Class A (STZ) is caught between its two moving averages. At $130.63 the stock sits 8.11% below its 200-day average of $142.15, yet it is 4.11% above its 50-day average of $125.47. Because the 50-day average is 11.74% below the 200-day average, the longer-term trend has not yet turned higher, even though the price has moved back above the shorter average. Across its 52-week range, which runs from $110.60 to $168.60, the price currently stands at 35% of the way up.
Recent gains sit on top of a weaker longer record. Over the past month the price rose 14.96%, but over the past three months it fell 1.05% and over the past year it fell 5.31%. In the last session the price fell 3.68% on volume that was 31.0% above its average. The 14-day RSI reads 56.0, which is neutral territory, and the MACD line is positive.
Earnings beat ›
The October 6, 2026 report beat the EPS estimate by 5.35%, and the share price rose 2.35% in the first session after it.
Source: Earnings report, October 6, 2026Analyst upgrade ›
Freedom Broker upgraded it to Buy from Hold on October 8, 2026.
Source: Analyst action, Freedom Broker, October 8, 2026
Rating reaffirmed ›
JP Morgan kept its Neutral rating on October 8, 2026.
Source: Analyst action, JP Morgan, October 8, 2026
- The two closest levels to watch are the 200-day SMA at $142.15, which sits above the price, and the 20-day EMA at $128.56, which sits below it.
- The 14-day RSI reads 56.0, in the neutral zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
- STZ rose 2.35% in the first session after its October 6, 2026 report. Over the 6 reports in our data, it has beaten estimates in 5 of them.
STZ's trend is mixed, with the price above the 50-day average at $125.47 but below the 200-day average at $142.15. If the price closes above the 200-day, both signals would point up; a close below the 50-day would point both down. For now the price sits between the 20-day EMA ($128.56) below it and the 200-day SMA ($142.15) above it.
With a 14-day RSI of 56.0, STZ is in the neutral zone, which runs from 40 to 60.
Technical indicators
Momentum and trend for STZ, from its daily closes.
As of October 27, 2026, with STZ at $130.63, its 14-day RSI is 56.0 (neutral territory), its 50-day simple moving average is $125.47 and its 200-day is $142.15.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What STZ moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, STZ's 1-year correlation of daily returns is +0.14 with S&P 500 (SPY), +0.04 with Nasdaq 100 (QQQ), -0.10 with Bitcoin (BTC) and +0.04 with gold (XAU).
STZ price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
14 of 24 analysts rate it a buy or strong buy, 8 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $150.00 is 14.8% above the price.More buy ratings than three months ago ›
14 of 24 rate it a buy now, against 14 of 24 three months ago.
STZ Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 8, 2026 | JP Morgan | Maintains | Neutral |
| Oct 8, 2026 | Freedom Broker | Upgrade | Buy |
| Oct 8, 2026 | UBS | Maintains | Buy |
| Oct 8, 2026 | Piper Sandler | Maintains | Neutral |
| Oct 8, 2026 | Deutsche Bank | Maintains | Hold |
| Oct 8, 2026 | RBC Capital | Maintains | Outperform |
As of October 27, 2026, 24 Wall Street analysts cover STZ: 14 rate it a buy or strong buy, 8 a hold and 2 a sell or strong sell. Their 12-month price targets range from $99.00 to $209.00. The median STZ price target is $150.00, 14.8% above the price of $130.63.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
STZ trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
STZ trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from STZ's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much STZ tends to move, against the market and on its own.
STZ price history and drawdowns
STZ's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 1.91% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 56.0%, from March 2024 to October 2026; the price is still 49.1% below that peak.Most 1-year holds ended higher ›
54% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $10,534, against $42,015 in the S&P 500 (SPY).
STZ Drawdowns & Recovery
As of October 27, 2026, STZ's worst peak-to-trough fall over the last 10 years with dividends reinvested was -56.0% (March 2024 to October 2026); it is still 49.1% below that peak, and 54% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into STZ in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: STZ trailed the S&P 500 over this period: $10,534 against $42,015.
A $10,000 investment in STZ in October 2016 would be worth about $10,534 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to STZ, and which have not.
Strongest month, April: an average of +6.19%, up in 9 of 10 years.
Weakest month, September: an average of -2.95%, up in 5 of 10 years.
This month, October: has averaged -2.85%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, STZ's strongest calendar month has been April (average +6.19%, up in 9 of 10 years) and its weakest September (average -2.95%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
STZ stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in STZ, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in STZ today could grow to about $10,820 by 2030 in the base case, with a 90th-percentile outcome near $21,948 and a 10th-percentile outcome around $5,334. The simulation models price only; at today's 3.14% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
STZ Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $141 for STZ by 2030 in the base case, from $131 today (1.1x over 4 years). The 10th-percentile path ends near $69.68. These are outcomes of a Monte Carlo simulation run on STZ's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $93.54 | $133 | $190 | |
| 2028 | $82.41 | $136 | $224 | |
| 2029 | $75.11 | $139 | $256 | |
| 2030 | $69.68 | $141 | $287 |
Method: a lognormal simulation of STZ's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
STZ insider trading
What the people running the company have bought and sold.
STZ insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $341K on the open market and sold $1.8M.
As of October 27, 2026, STZ insiders reported 5 open-market sales worth $1.8M and 1 open-market purchase worth $341K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Christopher J. Baldwin
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Christy Clark
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Jennifer M. Daniels
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Nicholas I. Fink
Chief Executive Officer
|
Grant | 1.1K | - |
| Jul 10, 2026 | Edith Morgan Flatley
Director
|
Grant | 187 | - |
| Jul 10, 2026 | William T Giles
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Ernesto M. Hernandez
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Garza Jose Manuel Madero
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Daniel J Mccarthy
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Richard Sands
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.1K | - |
| Jul 10, 2026 | Robert S Sands
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.1K | - |
| Jul 10, 2026 | Luca Zaramella
Director
|
Grant | 1.1K | - |
| May 12, 2026 | James O Bourdeau
Officer
|
Sell | 4.4K | $631.3K |
| May 1, 2026 | James O Bourdeau
Officer
|
Grant | 6.0K | - |
| May 1, 2026 | Paula Kristine Erickson
Officer
|
Grant | 1.8K | - |
| May 1, 2026 | Samuel J Glaetzer
Officer
|
Grant | 2.8K | - |
| May 1, 2026 | Garth Hankinson
Chief Financial Officer
|
Grant | 7.5K | - |
| May 1, 2026 | Jeffrey H. Labarge
Officer
|
Grant | 1.6K | - |
| May 1, 2026 | Michael Mcgrew
Officer
|
Grant | 2.1K | - |
| May 1, 2026 | Mallika Monteiro
Officer
|
Grant | 2.9K | - |
| May 1, 2026 | James Anthony Sabia Jr.
Officer
|
Grant | 5.5K | - |
| Apr 27, 2026 | Ernesto M. Hernandez
Director
|
Sell | 2.0K | $307.8K |
| Feb 17, 2026 | Samuel J Glaetzer
Officer
|
Sell | 555 | $85.3K |
| Jul 21, 2025 | James O Bourdeau
Officer
|
Sell | 821 | $138.7K |
| Jul 10, 2025 | Christopher J. Baldwin
Chairman of the Board
|
Grant | 503 | - |
| Jul 10, 2025 | Christy Clark
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Jennifer M. Daniels
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Nicholas I. Fink
Director
|
Grant | 503 | - |
| Jul 10, 2025 | William T Giles
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Ernesto M. Hernandez
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Garza Jose Manuel Madero
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Daniel J Mccarthy
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Richard Sands
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 503 | - |
| Jul 10, 2025 | Robert S Sands
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 503 | - |
| Jul 10, 2025 | Luca Zaramella
Director
|
Grant | 503 | - |
| Jul 8, 2025 | Christopher J. Baldwin
Director
|
Buy | 2.0K | $340.9K |
| May 13, 2025 | Samuel J Glaetzer
Officer
|
Sell | 3.2K | $593.9K |
| May 1, 2025 | James O Bourdeau
Officer
|
Grant | 3.4K | - |
| May 1, 2025 | Samuel J Glaetzer
Officer
|
Grant | 1.9K | - |
| May 1, 2025 | Garth Hankinson
Chief Financial Officer
|
Grant | 3.5K | - |
| May 1, 2025 | Michael Mcgrew
Officer
|
Grant | 1.0K | - |
| May 1, 2025 | Mallika Monteiro
Officer
|
Grant | 2.0K | - |
| May 1, 2025 | William A Newlands
Chief Executive Officer
|
Grant | 12.8K | - |
| May 1, 2025 | James Anthony Sabia Jr.
Officer
|
Grant | 2.4K | - |
Source: TwelveData, from SEC Form 4 filings
STZ stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.